SC 13G/A: Reneo Pharmaceuticals, Inc.

AI Summary

SC 13G/A filing by Reneo Pharmaceuticals, Inc..

Risk Assessment

Risk Level: low

Key Financial Figures

• $0.0001 — ame of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securiti

Filing Documents

• bml13g.htm (SC 13G/A) — 75KB
• 0001373604-24-000032.txt ( ) — 76KB

(a)

Item 1(a). Name of Issuer: Reneo Pharmaceuticals, Inc.

(b)

Item 1(b). Address of Issuer's Principal Executive Offices: 18575 Jamboree Road, Suite 275-S , Irvine , CA

(a)

Item 2(a). Name of Person Filing: BML Investment Partners, L.P.

(b)

Item 2(b). Address of Principal Business Office or, if none, Residence: 65 E. Cedar - Suite 2 Zionsville, IN 46077

(c)

Item 2(c). Citizenship: Delaware

(d)

Item 2(d). Title of Class of Securities: Common Stock, par value $0.0001 per share

(e)

Item 2(e). CUSIP Number: 75974E103 Item 3. If This Statement Is Filed Pursuant to Sections 240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing Is a(n): (a) Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o); (b) Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c) Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d) Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) Investment adviser in accordance with Section 240.13d-1(b)(1)(ii)(E); (f) Employee benefit plan or endowment fund in accordance with Section 240.13d-1(b)(1)(ii)(F); (g) Parent holding company or control person in accordance with Section 240.13d-1(b)(1)(ii)(G); (h) Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J); (k) Group, in accordance with Section 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____________________________ . Item 4. (a) Amount beneficially owned: 3,692,963 (b) Percent of class: 11.0% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 1,020,769 (ii) Shared power to vote or to direct the vote: 2,672,194 (iii) Sole power to dispose or to direct the disposition of: 1,020,769 (iv) Shared power to dispose or to direct the disposition of: 2,672,194 Item 5. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five p

View Full Filing

View this SC 13G/A filing on SEC EDGAR